Pharmaceutical Commerce - August 2023

Click the title above for a link to open the Pharmaceutical Commerce August 2023 issue in an interactive PDF format.

The August issue varies in subject matters, from the outlook for drug wholesaling to the value of a user-centric approach for drug adherence.

As Pharma Commerce continues to increase its conference exposure, it all could not have been possible without the help of colleagues.

Pharma Commerce team attends DIA's Annual Meeting for the first time.

A dive into the issue of evidence gaps, plus the case for a chief access officer.

While an option for financial assistance, patients should consider the challenges.

How the ‘fight-for-the-dollar’ is coming and likely will impact the bundled pricing of industry stakeholders.

Creating a user-centric approach that harnesses both digital tools and behavioral science is key to getting—and maintaining—patients on therapy, and improving clinical, financial, and, ultimately, brand-success outcomes for pharma manufacturers.

Companies' emphasis on delivering pharmaceuticals is evolving into a collaboration focused on healthcare outcomes.

The key questions and considerations for drug manufacturers pursuing an effective alternative distribution model.

Offer potential to improve patient care, including in medication adherence.

The importance of industry, as it moves forward, in focusing on patient-centered care and prioritizing patient needs across the supply chain.